Enterprise Value

22.61M

Cash

10.48M

Avg Qtr Burn

-9.714M

Short % of Float

0.29%

Insider Ownership

1.65%

Institutional Own.

6.69%

Qtr Updated

12/31/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
XACIATO (DARE-BV1) Details
Bacterial infection

Approved

Quarterly sales

Ovaprene® Details
Contraceptive

Phase 3

Data readout

Sildenafil Cream, 3.6% Details
Sexual dysfunction, Sexual desire disorder

Phase 3

Initiation

Phase 2

Initiation

DARE-PDM1 Details
Primary dysmenorrhea

Phase 1

Update

DARE-PTB1 Details
Preterm birth

Phase 1

Initiation

IND

Submission